Lung Cancer Deaths and Diagnoses Have Dropped
While national trends show significant improvements, disparities in survival persist across education and geographic lines.
Updated on Oct. 14, 2026 in Cancer
Live Poll
Do you trust that national health initiatives are successfully reducing the burden of lung cancer?
Recent data reveals that lung cancer death and diagnosis rates have declined significantly in the U.S. over the last two decades. While survival rates have doubled, uptake for early screening remains low for those currently eligible.
Why it matters
Falling smoking rates have driven these historic improvements in mortality. However, the report highlights that significant gaps in cancer outcomes remain tied to education levels, rural living, and racial backgrounds.
A long-term analysis tracked lung cancer trends, noting that the five-year relative survival rate increased to 30% by 2018 from a 15% baseline in 2000. Diagnosis and death rates also fell markedly across both men and women during the study period.
The details
The decline in mortality is largely attributed to decreased adult cigarette smoking and reduced secondhand smoke exposure. Early detection, facilitated by low-dose CT screening, has also helped, with early-stage diagnosis rates rising to 33% in women and 27% in men. Patients diagnosed today often benefit from advanced treatment modalities, including targeted therapy and immunotherapy, which have contributed to improved survival outcomes.
Timeline
2000: Baseline for five-year relative survival rate measurement.
2001: Baseline for adult cigarette smoking prevalence measurement.
2003-2022: Period for lung cancer diagnosis rate decline.
2004-2023: Period for lung cancer death rate decline.
2024: Measurement year for cigarette smoking and screening rates.
Health Landscape
This report maps the positive health trajectory associated with the historical decline in U.S. adult cigarette smoking. It follows a multi-decade trend of improving cancer outcomes through better prevention and specialized treatment.
Given that only 18% of eligible adults are currently up to date on screenings, it is important to confirm your eligibility for low-dose CT scans with your doctor. Being aware of these regional and educational disparities can help you better understand your personal risk factors.
The takeaway
While survival rates have improved, the persistent 40% higher death rate in rural areas serves as an important reminder of the role geography plays in healthcare access. Talk to your primary care provider about your smoking history and whether you qualify for early lung cancer screening.
Further reading
Learn more about the latest developments in lung health within our Cancer section.
Source note: This article includes information reported by Curetoday.
Live Poll
Do you trust that national health initiatives are successfully reducing the burden of lung cancer?
